Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Fierce Pharma
Wed, 10/23/24 - 10:26 pm
Tags:
Roche, Novo Holdings, Catalent, CDMOs, M&A, drug manufacturing
Roche culls cough candidate, pivots KRAS program after revaluing entire pipeline
Fierce Biotech
Wed, 10/23/24 - 11:29 am
Tags:
Roche, chronic cough, KRAS, Genentech
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Fierce Biotech
Tue, 10/22/24 - 11:25 am
Tags:
Roche, UCB Pharma, anti-tau antibodies, bepranemab, Alzheimer's disease
Roche reports topline data from trial of Vabysmo for diabetic macular edema
Clinical Trials Arena
Mon, 10/21/24 - 09:44 am
Tags:
Roche, Vabysmo, diabetic macular edema
Another Roche MAGE-A4 trial disappears, withdrawn without enrolling after strategic review
Fierce Biotech
Fri, 10/18/24 - 11:34 am
Tags:
Roche, MAGE-A4, clinical trials, solid tumors, bispecific antibodies, Genentech
Jazz's almost-withdrawn lung cancer drug Zepzelca extends life on top of Roche’s Tecentriq
Fierce Pharma
Tue, 10/15/24 - 11:03 am
Tags:
Jazz Pharma, Zepzelca, extensive-stage small cell lung cancer, Roche, Tecentriq
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
Clinical Trials Arena
Tue, 10/15/24 - 10:16 am
Tags:
Roche, SMA, spinal muscular atrophy, Evrysdi, clinical trials
Roche gets FDA green light for breast cancer drug Itovebi
Pharmaphorum
Fri, 10/11/24 - 09:34 am
Tags:
Roche, FDA, Itovebi, metastatic breast cancer
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Reuters
Wed, 10/9/24 - 09:44 am
Tags:
Roche, breast cancer, Giredestrant, clinical trials
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
Tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Genentech buys Regor's next-gen CDK inhibitors for $850M
Pharmaphorum
Tue, 10/1/24 - 09:46 am
Tags:
Regor Therapeutics, Roche, Genentech, CDK inhibitors
Roche targets more than $3 billion in annual obesity sales
Reuters
Mon, 09/30/24 - 10:09 am
Tags:
Roche, Carmot Therapeutics, obesity, diabetes
Roche looks to grow Gazyva's reach with phase 3 lupus nephritis win
Fierce Pharma
Thu, 09/26/24 - 06:27 pm
Tags:
Roche, Gazyva, clinical trials, lupus nephritis
Roche reports positive data from Phase III influenza treatment trial
Clinical Trials Arena
Thu, 09/19/24 - 09:24 am
Tags:
Roche, Flu, clinical trials, Xofluza
Obesity pill race heats up as Novo, Roche and Terns share data
BioSpace
Tue, 09/17/24 - 11:22 am
Tags:
obesity, Novo Nordisk, Roche, Terns Pharmaceuticals, amycretin, TERN-601, CT-996, clinical trials
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Fierce Pharma
Sun, 09/15/24 - 06:17 pm
Tags:
Roche, Genentech, Ocrevus, MS, Ocrevus Zunovo
FDA approves Roche’s Tecentriq Hybreza for cancer
Yahoo Finance
Fri, 09/13/24 - 09:33 am
Tags:
Roche, FDA, Tecentriq Hybreza, cancer
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Fierce Biotech
Wed, 09/11/24 - 11:15 pm
Tags:
Roche, obesity, CT-388, Carmot Therapeutics
Roche ramps up R&D with $1.4B Swiss facility
Fierce Biotech
Wed, 09/11/24 - 11:55 am
Tags:
Roche, R&D, Switzerland
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
Tags:
weight loss, obesity, Amgen, Pfizer, Roche, Novo Nordisk, Eli Lilly, Boehinger Ingelheim, Structure Therapeutics, Viking Therapeutics, Zealand Pharma, Altimmune

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.